These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 8962184

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Leflunomide derivative FK778 inhibits production of antibodies in an experimental model of alloreactive T-B cell interaction.
    Ramos-Barrón MA, Gómez-Alamillo C, Santiuste I, Agüeros C, Cosme LS, Benito A, Gimenez T, Merino J, Merino R, Arias M.
    Exp Clin Transplant; 2009 Dec; 7(4):218-24. PubMed ID: 20353370
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Inhibition of alloreactivity in the popliteal lymph node assay by malononitrilamides.
    Schorlemmer HU, Bartlett RR, Kurrle R.
    Transplant Proc; 1998 Jun; 30(4):968-70. PubMed ID: 9636391
    [No Abstract] [Full Text] [Related]

  • 8. Didemnin B: an immunosuppressive cyclic peptide that stimulates murine antibody responses in vivo and in vitro.
    Montgomery DW, Celniker A, Zukoski CF.
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1295-6. PubMed ID: 3274320
    [No Abstract] [Full Text] [Related]

  • 9. Combination therapy of malononitrilamide FK778 with tacrolimus on cell proliferation assays and in rats receiving renal allografts.
    Vu MD, Qi S, Wang X, Jiang W, Ma A, Xu D, Bekersky I, Fitzsimmons WE, Wu J, Chen H.
    Transplantation; 2003 May 15; 75(9):1455-9. PubMed ID: 12792496
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Successful treatment of fulminant hepatitis B and fulminant hepatitis B and D coinfection explained by inhibitory effect on the immune response?
    Hansson BG, Riesbeck K, Nordenfelt E, Weiland O.
    Prog Clin Biol Res; 1991 May 15; 364():421-7. PubMed ID: 1826956
    [Abstract] [Full Text] [Related]

  • 12. The novel immunosuppressant FK778 inhibits formation of the immunologic Synapse.
    Zeyda M, Geyeregger R, Poglitsch M, Watschinger B, Hörl WH, Stulnig TM, Säemann MD.
    Transplant Proc; 2005 May 15; 37(4):1970-1. PubMed ID: 15919521
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of leflunomide on T-independent xenoantibody formation in rats receiving hamster heart xenografts.
    Lin Y, Vandeputte M, Waer M.
    Transplant Proc; 1996 Apr 15; 28(2):952. PubMed ID: 8623477
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Redundant and unique regulation of activated mouse B lymphocytes by IL-4 and IL-21.
    Jin H, Malek TR.
    J Leukoc Biol; 2006 Dec 15; 80(6):1416-23. PubMed ID: 16943384
    [Abstract] [Full Text] [Related]

  • 18. Human B cell growth factors overcome T cell-mediated inhibition of specific antibody production: a possible mechanism for the exacerbation of autoimmune disease.
    Brenner MK, North ME.
    Clin Exp Immunol; 1983 Jun 15; 52(3):635-40. PubMed ID: 6603301
    [Abstract] [Full Text] [Related]

  • 19. [Levamisole and thyroid diseases].
    Epishin AV.
    Klin Med (Mosk); 1983 Nov 15; 61(11):21-4. PubMed ID: 6198555
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.